SeV iPS cells

About SeV iPS cells

This is a line of clinical-grade iPS cells made using Sendai Virus (SeV) vectors. SeV-iPS cells satisfy Japanese, European, and North American regulations for clinical use, made from the peripheral blood of an American donor collected and tested in authorized medical and research institutions in the U.S.

Glossary

Sendai virus (SeV) vector: A "vector" in genetics is a biomaterial, usually virus or plasmid (circular DNA), that transduces genes into cells. Some vectors, however, integrate into the cell's genome, risking cytotoxicity and genetic disorders. SeV vectors do not have this concern.

SeV iPS Cell Stock list

Clinical-grade cells

Service Cost
For-profit entities 100,000 yen/vial
Non-profit entities Free
  • *Approval from the iPS Cell Stock Committee is required before cells can be provided.
  • *Even when you apply for research purpose (non-clinical), a clinical-grade cell line is provided.Under the research condition, do not use in humans.
  • *International Shipping: The receiving organization, whether profit or non-profit, is responsible for shipping and transporting arrangements and costs from CiRA Foundation to its research location. CiRA Foundation is not responsible for any loss or damage during shipment or transportation.

Donor ID Clone ID
KTRH KTRH05
KTRH26

User registration for Clinical-grade cells

Please click 「How to apply for iPS Cell Stock」
You may apply for more than one cell line at a time.